Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Remission Induction"" wg kryterium: Temat


Tytuł :
Moving the Goalpost Toward Remission: The Case for Combination Immunomodulatory Therapies in Psoriatic Arthritis.
Autorzy :
Scher JU; New York University School of Medicine and NYU Langone Orthopedic Hospital, New York, New York.
Ogdie A; University of Pennsylvania Perelman School of Medicine, Philadelphia.
Merola JF; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Ritchlin C; University of Rochester School of Medicine and Dentistry, Rochester, New York.
Pokaż więcej
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Sep; Vol. 73 (9), pp. 1574-1578. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunomodulation*
Remission Induction*
Antirheumatic Agents/*therapeutic use
Arthritis, Psoriatic/*drug therapy
Drug Therapy, Combination ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
PiggyBac -Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report.
Autorzy :
Li C; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Sun Y; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Wang J; Radiology Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tang L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Jiang H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Guo T; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Liu L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Ai L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xia L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wu J; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Lin Z; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Qian Q; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 May 25; Vol. 12, pp. 599493. Date of Electronic Publication: 2021 May 25 (Print Publication: 2021).
Typ publikacji :
Case Reports; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy, Adoptive*
Remission Induction*
Lenalidomide/*administration & dosage
Lymphoma, Large B-Cell, Diffuse/*therapy
Humans ; Lymphoma, Large B-Cell, Diffuse/immunology ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Middle Aged ; Recurrence
Czasopismo naukowe
Tytuł :
Anxiety in Late-Life Depression: Determinants of the Course of Anxiety and Complete Remission.
Autorzy :
van der Veen DC; Department of Psychiatry (DCVDV, WVZ, RAS, RCOV), University of Groningen, University Medical Center Groningen, Interdisciplinary Center of Psychopathology of Emotion regulation (ICPE), Groningen, The Netherlands. Electronic address: .
Gulpers B; Regional Institute for Mental Health Care in Outpatients, RIAGG Maastricht (BG), Maastricht, The Netherlands; Department of Psychiatry and Psychology/MUMC, School for Mental Health and Neuroscience (MHeNS)/Alzheimer Centre Limburg (BG), Maastricht University Medical Center, Maastricht, The Netherlands.
van Zelst W; Department of Psychiatry (DCVDV, WVZ, RAS, RCOV), University of Groningen, University Medical Center Groningen, Interdisciplinary Center of Psychopathology of Emotion regulation (ICPE), Groningen, The Netherlands.
Köhler S; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience and Alzheimer Centre Limburg (SK), Maastricht University Medical Center, Maastricht, The Netherlands.
Comijs HC; Department of Psychiatry (HCC), Amsterdam Public Health Research Institute, GGZ inGeest/VU University Medical Centre, Amsterdam, The Netherlands.
Schoevers RA; Department of Psychiatry (DCVDV, WVZ, RAS, RCOV), University of Groningen, University Medical Center Groningen, Interdisciplinary Center of Psychopathology of Emotion regulation (ICPE), Groningen, The Netherlands.
Oude Voshaar RC; Department of Psychiatry (DCVDV, WVZ, RAS, RCOV), University of Groningen, University Medical Center Groningen, Interdisciplinary Center of Psychopathology of Emotion regulation (ICPE), Groningen, The Netherlands.
Pokaż więcej
Źródło :
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry [Am J Geriatr Psychiatry] 2021 Apr; Vol. 29 (4), pp. 336-347. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :
Journal Article
MeSH Terms :
Life Change Events*
Personality*
Remission Induction*
Anxiety/*diagnosis
Anxiety/*therapy
Anxiety Disorders/*diagnosis
Anxiety Disorders/*therapy
Depressive Disorder, Major/*complications
Aged ; Aged, 80 and over ; Anxiety/complications ; Anxiety/psychology ; Anxiety Disorders/complications ; Anxiety Disorders/psychology ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Netherlands ; Neuroticism ; Prognosis ; Self Report
Czasopismo naukowe
Tytuł :
Higher-Calorie Refeeding in Anorexia Nervosa: 1-Year Outcomes From a Randomized Controlled Trial.
Autorzy :
Golden NH; Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California; .
Cheng J; Department of Preventive and Restorative Dental Sciences, School of Dentistry, University of California, San Francisco, San Francisco, California.
Kapphahn CJ; Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Buckelew SM; Division of Adolescent and Young Adult Medicine, Departments of Pediatrics.
Machen VI; Division of Adolescent and Young Adult Medicine, Departments of Pediatrics.
Kreiter A; Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Accurso EC; Psychiatry and Behavioral Sciences.
Adams SH; Division of Adolescent and Young Adult Medicine, Departments of Pediatrics.
Le Grange D; Psychiatry and Behavioral Sciences.; Department of Psychiatry and Behavioral Neuroscience, School of Medicine, The University of Chicago, Chicago, Illinois; and.
Moscicki AB; Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California, Los Angeles, Los Angeles, California.
Sy AF; Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Wilson L; Medicine, and Clinical Pharmacy, University of California, San Francisco, San Francisco, California.
Garber AK; Division of Adolescent and Young Adult Medicine, Departments of Pediatrics.
Pokaż więcej
Źródło :
Pediatrics [Pediatrics] 2021 Apr; Vol. 147 (4). Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Energy Intake*
Remission Induction*
Anorexia Nervosa/*therapy
Patient Readmission/*statistics & numerical data
Adolescent ; Female ; Follow-Up Studies ; Humans ; Male ; Recurrence
Czasopismo naukowe
Tytuł :
What is remission in gout and how should we measure it?
Autorzy :
Dalbeth N; Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Stamp LK; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Taylor WJ; Department of Medicine, University of Otago Wellington, Wellington South, New Zealand.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 Mar 02; Vol. 60 (3), pp. 1007-1009.
Typ publikacji :
Journal Article
MeSH Terms :
Remission Induction*
Gout/*drug therapy
Uric Acid/*blood
Biomarkers/blood ; Gout Suppressants/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.
Autorzy :
Mingrone G; Department of Medical and Surgery Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Diabetes, Università Cattolica del Sacro Cuore Rome, Rome, Italy; Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. Electronic address: .
Panunzi S; Laboratorio di Biomatematica, Consiglio Nazionale delle Ricerche, Istituto di Analisi dei Sistemi ed Informatica, Rome, Italy.
De Gaetano A; Laboratorio di Biomatematica, Consiglio Nazionale delle Ricerche, Istituto di Analisi dei Sistemi ed Informatica, Rome, Italy.
Guidone C; Department of Medical and Surgery Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Diabetes, Università Cattolica del Sacro Cuore Rome, Rome, Italy.
Iaconelli A; Department of Medical and Surgery Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Diabetes, Università Cattolica del Sacro Cuore Rome, Rome, Italy.
Capristo E; Department of Medical and Surgery Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Diabetes, Università Cattolica del Sacro Cuore Rome, Rome, Italy.
Chamseddine G; Department of Diabetes, Bariatric and Metabolic Surgery, King's College Hospital, London, UK.
Bornstein SR; Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK; Department of Medicine III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany.
Rubino F; Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK; Department of Diabetes, Bariatric and Metabolic Surgery, King's College Hospital, London, UK.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jan 23; Vol. 397 (10271), pp. 293-304.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Bariatric Surgery*
Biliopancreatic Diversion*
Remission Induction*
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*therapeutic use
Adult ; Body Mass Index ; Diabetes Complications ; Female ; Follow-Up Studies ; Glycated Hemoglobin A/metabolism ; Humans ; Italy ; Male
Czasopismo naukowe
Tytuł :
Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis.
Autorzy :
Kato M; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan. .
Hori H; Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan.
Inoue T; Department of Psychiatry, Tokyo Medical University, Tokyo, Japan.
Iga J; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan.
Iwata M; Department of Neuropsychiatry, Faculty of Medicine, Tottori University, Yonago, Japan.
Inagaki T; Adolescent Mental Health Service, Biwako Hospital, Otsu, Japan.; Department of Psychiatry, Shiga University of Medical Science, Otsu, Japan.
Shinohara K; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan.
Imai H; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan.
Murata A; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
Mishima K; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
Tajika A; Department of Psychiatry, Kyoto University Hospital, Kyoto, Japan.
Pokaż więcej
Źródło :
Molecular psychiatry [Mol Psychiatry] 2021 Jan; Vol. 26 (1), pp. 118-133. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Remission Induction*
Antidepressive Agents/*administration & dosage
Antidepressive Agents/*therapeutic use
Depressive Disorder, Major/*drug therapy
Antidepressive Agents, Tricyclic/administration & dosage ; Antidepressive Agents, Tricyclic/therapeutic use ; Controlled Clinical Trials as Topic ; Depression/drug therapy ; Humans ; Serotonin Uptake Inhibitors/administration & dosage ; Serotonin Uptake Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł :
A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
Autorzy :
Zhang Z; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Taylor L; Department of Medicine, University of Calgary, Calgary, AB, Canada.
Shommu N; Department of Medicine, University of Calgary, Calgary, AB, Canada.
Ghosh S; Institute of Translational Medicine, NIHR Biomedical Research Centre, University of Birmingham and Birmingham University Hospitals, Birmingham, UK.
Reimer R; Faculty of Kinesiology, University of Calgary, Calgary, Canada.
Panaccione R; Department of Medicine, University of Calgary, Calgary, AB, Canada.
Kaur S; Department of Medicine, University of Calgary, Calgary, AB, Canada.
Hyun JE; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Cai C; Program for Pregnancy and Postpartum Health, Women and Children's Health Research Institute, University of Alberta, Edmonton, Canada.
Deehan EC; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada.
Hotte N; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Madsen KL; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Raman M; Department of Medicine, University of Calgary, Calgary, AB, Canada.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Nov 07; Vol. 14 (11), pp. 1547-1557.
Typ publikacji :
Journal Article
MeSH Terms :
Crohn Disease*/diagnosis
Crohn Disease*/diet therapy
Crohn Disease*/microbiology
Crohn Disease*/physiopathology
Diet*/classification
Diet*/methods
Dysbiosis*/etiology
Dysbiosis*/microbiology
Remission Induction*
Eating/*physiology
Gastrointestinal Microbiome/*physiology
Adult ; Correlation of Data ; Escherichia/isolation & purification ; Faecalibacterium/isolation & purification ; Feces/chemistry ; Feces/microbiology ; Female ; Humans ; Leukocyte L1 Antigen Complex/analysis ; Male ; Outcome and Process Assessment, Health Care ; Shigella/isolation & purification
Czasopismo naukowe
Tytuł :
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Autorzy :
Abuhelwa AY; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia. .; Clinical and Health Sciences, University of South Australia, Adelaide, SA, 5000, Australia. .
Hopkins AM; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia.
Sorich MJ; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia.
Proudman S; Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.; Discipline of Medicine, University of Adelaide, Adelaide, SA, 5000, Australia.
Foster DJR; Clinical and Health Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
Wiese MD; Clinical and Health Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Oct 29; Vol. 10 (1), pp. 18634. Date of Electronic Publication: 2020 Oct 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Remission Induction*
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Obesity/*complications
Adult ; Arthritis, Rheumatoid/complications ; Body Mass Index ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Proportional Hazards Models
Czasopismo naukowe
Tytuł :
Lymphodepletion chemotherapy revitalizes chimeric antigen receptor T cells contributing to regression of relapsed B-cell lymphoma: A case report.
Autorzy :
Liang Z; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine.; Hematology Institution, Zhejiang University, Hangzhou.
Zhang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine.; Hematology Institution, Zhejiang University, Hangzhou.
Shao M; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine.; Hematology Institution, Zhejiang University, Hangzhou.
Cui Q; Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing.
Wu Z; Innovative Cellular Therapeutics Co., Ltd., Shanghai, China.
Xiao L; Innovative Cellular Therapeutics Co., Ltd., Shanghai, China.
Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine.; Hematology Institution, Zhejiang University, Hangzhou.
Hu Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine.; Hematology Institution, Zhejiang University, Hangzhou.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Oct 23; Vol. 99 (43), pp. e22510.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Lymphocyte Depletion*
Remission Induction*
Cyclophosphamide/*therapeutic use
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Receptors, Chimeric Antigen/*immunology
T-Lymphocytes/*immunology
Vidarabine/*analogs & derivatives
Adult ; Antigens, CD19/immunology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cytokine Release Syndrome/etiology ; Humans ; Male ; Neoplasm Recurrence, Local/drug therapy ; Vidarabine/therapeutic use
Czasopismo naukowe
Tytuł :
MR prediction of pathologic complete response and early-stage rectal cancer after neoadjuvant chemoradiation in patients with clinical T1/T2 rectal cancer for organ saving strategy.
Autorzy :
Bae H; Department of Radiology and Research Institute of Radiological Science.
Seo N; Department of Radiology and Research Institute of Radiological Science.
Han K; Department of Radiology and Research Institute of Radiological Science.
Koom WS; Department of Radiation Oncology, Yonsei Cancer Center.
Kim MJ; Department of Radiology and Research Institute of Radiological Science.
Kim NK; Division of Colorectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
Lim JS; Department of Radiology and Research Institute of Radiological Science.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Oct 16; Vol. 99 (42), pp. e22746.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Imaging*
Remission Induction*
Rectal Neoplasms/*diagnostic imaging
Rectal Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Chemoradiotherapy ; Early Detection of Cancer ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Organ Sparing Treatments ; Predictive Value of Tests ; Rectal Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab.
Autorzy :
Tomuleasa C; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania. .; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania. .
Iluta S; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania.
Pasca S; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
Roman A; Department of Radiology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj-Napoca, Romania.; Department of Radiology,, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
Piciu D; Department of Radiology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj-Napoca, Romania.; Department of Radiology,, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
Jitaru C; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
Teodorescu P; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania.
Rus I; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania.
Bojan A; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania.
Dima D; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
Zdrenghea M; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania.
Petrushev B; Medfuture Research Center, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj-Napoca, Romania.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Oct; Vol. 112 (4), pp. 597-598. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Remission Induction*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Immunotherapy/*methods
Lenalidomide/*administration & dosage
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Rituximab/*administration & dosage
Aged, 80 and over ; Humans ; Lymphoma, Large B-Cell, Diffuse/diagnostic imaging ; Male ; Neoplasm Recurrence, Local ; Positron Emission Tomography Computed Tomography ; Treatment Outcome
Raport
Tytuł :
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
Autorzy :
Stasik S; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Eckardt JN; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Kramer M; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Röllig C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Krämer A; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
Scholl S; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
Crysandt M; Klinik für Hämatologie, Onkologie, Hämostasiologie und Stammzelltransplantation , Uniklinik RWTH Aachen, Aachen, Germany.
Brümmendorf TH; Klinik für Hämatologie, Onkologie, Hämostasiologie und Stammzelltransplantation , Uniklinik RWTH Aachen, Aachen, Germany.
Naumann R; Medizinische Klinik III, St. Marien-Krankenhaus Siegen, Siegen, Germany.
Steffen B; Medizinische Klinik II, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany.
Kunzmann V; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
Einsele H; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
Schaich M; Klinik für Hämatologie, Onkologie und Palliativmedizin, Rems-Murr-Klinikum Winnenden, Winnenden, Germany.
Burchert A; Klinik für Hämatologie, Onkologie, Immunologie, Philipps Universität Marburg, Marburg, Germany.
Neubauer A; Klinik für Hämatologie, Onkologie, Immunologie, Philipps Universität Marburg, Marburg, Germany.
Schäfer-Eckart K; Klinik für Innere Medizin V, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg Nord, Nürnberg, Germany.
Schliemann C; Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany.
Krause S; Medizinische Klinik V, Paracelsus Medizinische Privatuniversität, Universitätsklinikum Erlangen, Erlangen, Germany.
Herbst R; Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany.
Hänel M; Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany.
Frickhofen N; Innere Medizin III, HSK Wiesbaden, Wiesbaden, Germany.
Noppeney R; Klinik für Hämatologie, Universitätsklinikum Essen, Essen, Germany.
Kaiser U; Medizinische Klinik II, St. Bernward Krankenhaus, Hildesheim, Germany.
Baldus CD; Hämatologie und Onkologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kaufmann M; Abteilung für Hämatologie, Onkologie und Palliativmedizin, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
Rácil Z; Masaryk University and University Hospital, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic.
Platzbecker U; Medizinische Klinik und Poliklinik I, Hämatologie und Zelltherapie, Universitätsklinikum Leipzig, Leipzig, Germany.
Berdel WE; Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany.
Mayer J; Masaryk University and University Hospital, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic.
Serve H; Medizinische Klinik II, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany.
Müller-Tidow C; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
Ehninger G; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Bornhäuser M; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Diseases, Dresden, Germany; and.
Schetelig J; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.; DKMS Clinical Trials Unit, Dresden, Germany.
Middeke JM; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Thiede C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Pokaż więcej
Corporate Authors :
Study Alliance Leukemia (SAL)
Źródło :
Blood advances [Blood Adv] 2021 Sep 14; Vol. 5 (17), pp. 3279-3289.
Typ publikacji :
Journal Article
MeSH Terms :
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Humans ; Mutation ; Phosphoprotein Phosphatases ; Prognosis ; Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics ; Remission Induction
Czasopismo naukowe
Tytuł :
Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
Autorzy :
Xue H; Department of Pediatric Hematology and Oncology, Xingtai People's Hospital, Xingtai, China.
Gao H; Department of Pediatric Hematology and Oncology, The Children's Hospital Affiliated of Zhengzhou University, Zhengzhou, China.
Xia H; Department of Pediatric, Xingtai People's Hospital, Xingtai, China.
Li S; Department of Digestive Endoscopy, Minmetals Hanxing General Hospital, Handan, China.
Li N; Department of Pediatric Hematology and Oncology, Xingtai People's Hospital, Xingtai, China.
Duan Y; Department of Pediatric Hematology and Oncology, Xingtai People's Hospital, Xingtai, China.
Ren Y; Department of Pediatric Hematology and Oncology, Xingtai People's Hospital, Xingtai, China.
Zhang H; Department of Pediatric Hematology and Oncology, Xingtai People's Hospital, Xingtai, China.
Liu J; Department of Pediatric Hematology and Oncology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
Gao W; Department of Pediatric Hematology and Oncology, Xingtai People's Hospital, Xingtai, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Sep 03; Vol. 100 (35), pp. e26959.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*analysis
Leukemia, Myeloid/*genetics
Leukemia, Myeloid/*mortality
RNA, Long Noncoding/*analysis
Child ; Child, Preschool ; Female ; Humans ; Leukemia, Myeloid/complications ; Male ; Prognosis ; Remission Induction
Czasopismo naukowe
Tytuł :
Skip, Stop, Switch, and Spare: Steroid Therapy in Inflammatory Bowel Disease.
Autorzy :
Harrison N; Gastroenterology Service, Department of Internal Medicine, San Antonio Military Medical Center, San Antonio, Texas, USA.; Department of Internal Medicine, Uniformed Services University, Bethesda, Maryland, USA.
Humes R; Department of Internal Medicine, Uniformed Services University, Bethesda, Maryland, USA.; Gastroenterology Service, Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Singla M; Capital Digestive Care, LLC, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło :
The American journal of gastroenterology [Am J Gastroenterol] 2021 Sep 01; Vol. 116 (9), pp. 1819-1821.
Typ publikacji :
Journal Article
MeSH Terms :
Adrenal Cortex Hormones/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Humans ; Remission Induction/methods ; Withholding Treatment
Czasopismo naukowe
Tytuł :
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.
Autorzy :
Garcia-Romero R; Paediatric Gastroenterology, Hepatology and Nutrition, Paediatric University Hospital Miguel Servet, Zaragoza, Spain. .
Martinez de Zabarte Fernandez JM; Paediatric Gastroenterology and Nutrition, Hospital Obispo Polanco, Teruel, Spain.
Pujol-Muncunill G; Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Sant Joan de Déu, Barcelona, Spain.
Donat-Aliaga E; Paediatric Gastroenterology, Hepatology and Nutrition, Polytechnic University Hospital La Fe, Valencia, Spain.
Segarra-Cantón O; Paediatric Gastroenterology, Hepatology and Nutrition, Mother-Child University Hospital, Vall Hebrón, Barcelona, Spain.
Irastorza-Terradillos I; Paediatric Gastroenterology, Hepatology and Nutrition, University Hospital of Cruces, Barakaldo, Spain.
Medina-Benitez E; Paediatric Gastroenterology, Hepatology and Nutrition Unit, University Hospital 12 de Octubre, Madrid, Spain.
Ruiz-Hernández CJ; Paediatric Gastroenterology and Nutrition, Department of Paediatrics, Hospital Parc Taulí, Sabadell, Spain.
Carrillo-Palau M; Department of Gastroenterology, University Hospital of the Canary Islands, La Laguna, Tenerife, Spain.
Ros-Arnal I; Paediatric Gastroenterology, Hepatology and Nutrition, Paediatric University Hospital Miguel Servet, Zaragoza, Spain.
Rodriguez-Martínez A; Paediatric Gastroenterology, Hepatology and Nutrition, University Hospital Virgen del Rocío, Sevilla, Spain.
Escartin-Madurga L; Paediatric Gastroenterology, Hepatology and Nutrition, University Clinic Hospital Lozano Blesa, Zaragoza, Spain.
Gutiérrez-Junquera C; Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Vicente-Santamaría S; Paediatric Gastroenterology, Hepatology and Nutrition, University Hospital Ramon y Cajal, Madrid, Spain.
Velasco Rodriguez-Belvis M; Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Niño Jesús, Madrid, Spain.
Fernández-Fernández S; Paediatric Gastroenterology, Hepatology and Nutrition, University Hospital Severo Ochoa, Leganés, Madrid, Spain.
Alberto-Alonso JR; Paediatric Gastroenterology, Hepatology and Nutrition, University Hospital Ntra. Sra. de Candelaria, Tenerife, Spain.
Montraveta M; Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Germans Trias i Pujol, Badalona, Spain.
Torres-Peral R; Paediatric Gastroenterology and Nutrition Unit, Department of Paediatrics, University Hospital Complex, Salamanca, Spain.
Navalon-Rubio M; Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Virgen de la Arrixaca, Murcia, Spain.
Navas-López VM; Paediatric Gastroenterology and Nutrition Section, Regional University Hospital of Malaga, Málaga, Spain.
Martin de Carpi J; Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Sant Joan de Déu, Barcelona, Spain.
Pokaż więcej
Źródło :
European journal of pediatrics [Eur J Pediatr] 2021 Sep; Vol. 180 (9), pp. 3029-3038. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Adolescent ; Antibodies, Monoclonal, Humanized ; Child ; Female ; Gastrointestinal Agents/adverse effects ; Humans ; Male ; Remission Induction ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Autorzy :
Chavatza K; Rheumatology and Clinical Immunology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital of Athens, Athens, Greece.
Kostopoulou M; Department of Nephrology, 'G. Gennimatas' General Hospital, Athens, Greece.
Nikolopoulos D; Rheumatology and Clinical Immunology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital of Athens, Athens, Greece.
Gioti O; Department of Rheumatology, 'Asklepieion' General Hospital, Voula, Athens, Greece.
Togia K; Rheumatology and Clinical Immunology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital of Athens, Athens, Greece.
Andreoli L; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; Unit of Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy.
Aringer M; Division of Rheumatology, Department of Medicine III, University Medical Center & Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany.
Boletis J; Nephrology Department and Renal Transplantation Unit, 'Laikon' Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Doria A; Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
Houssiau FA; Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
Jayne D; Department of Medicine, University of Cambridge, Cambridge, UK.
Mosca M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Svenungsson E; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Tincani A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Bertsias G; Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Crete, Greece.
Fanouriakis A; Rheumatology and Clinical Immunology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital of Athens, Athens, Greece.; Department of Rheumatology, 'Asklepieion' General Hospital, Voula, Athens, Greece.
Boumpas DT; Rheumatology and Clinical Immunology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital of Athens, Athens, Greece .; Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Sep; Vol. 80 (9), pp. 1175-1182. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Quality Indicators, Health Care*
Lupus Erythematosus, Systemic/*therapy
Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antirheumatic Agents/administration & dosage ; Aspirin/therapeutic use ; Drug Tapering ; Europe ; Female ; Glucocorticoids/administration & dosage ; Guideline Adherence/statistics & numerical data ; Hospitalization/statistics & numerical data ; Humans ; Hydroxychloroquine/administration & dosage ; Immunosuppressive Agents/therapeutic use ; Kidney/pathology ; Lupus Erythematosus, Systemic/diagnosis ; Lupus Nephritis/diagnosis ; Lupus Nephritis/therapy ; Male ; Mass Screening ; Osteoporosis/diagnosis ; Platelet Aggregation Inhibitors/therapeutic use ; Practice Guidelines as Topic ; Pre-Eclampsia/prevention & control ; Prednisone/administration & dosage ; Pregnancy ; Remission Induction ; Reproducibility of Results ; Risk Assessment ; Societies, Medical ; Symptom Flare Up
Czasopismo naukowe
Tytuł :
Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study.
Autorzy :
Coates LC; University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences and Oxford University Hospitals NHS Foundation Trust, NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pillai SG; Eli Lilly and Company, Indianapolis, Indiana.
Tahir H; Royal Free London NHS Trust and University College London, Division of Medicine, London, UK.
Valter I; Center for Clinical and Basic Research, Tallinn, Estonia.
Chandran V; University of Toronto and Krembil Research Institute, University Health Network, Toronto, Ontario, Canada, and Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Kameda H; Toho University, Tokyo, Japan.
Okada M; Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo.
Kerr L; Eli Lilly and Company, Indianapolis, Indiana.
Alves D; Eli Lilly and Company, Indianapolis, Indiana.
Park SY; Eli Lilly and Company, Indianapolis, Indiana.
Adams DH; Eli Lilly and Company, Indianapolis, Indiana.
Gallo G; Eli Lilly and Company, Indianapolis, Indiana.
Hufford MM; Eli Lilly and Company, Indianapolis, Indiana.
Hojnik M; Eli Lilly and Company, Indianapolis, Indiana.
Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle.
Kavanaugh A; University of California San Diego.
Pokaż więcej
Corporate Authors :
SPIRIT-P3 Study Group
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Sep; Vol. 73 (9), pp. 1663-1672. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Antirheumatic Agents/*therapeutic use
Arthritis, Psoriatic/*drug therapy
Dermatologic Agents/*therapeutic use
Adult ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Remission Induction ; Treatment Outcome ; Withholding Treatment
Czasopismo naukowe
Tytuł :
Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.
Autorzy :
Gupta A; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Yu A; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Peyrin-Biroulet L; Department of Gastroenterology, Nancy University Hospital, Vandoeuvre-les-Nancy, France; French Institute of Health and Medical Research U1256 NGERE, University of Lorraine, Vandoeuvre-les-Nancy, France.
Ananthakrishnan AN; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Sep; Vol. 19 (9), pp. 1800-1813.e4. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Colitis*
Colitis, Ulcerative*
Crohn Disease*
Inflammatory Bowel Diseases*
Humans ; Remission Induction
Czasopismo naukowe
Tytuł :
[Recommendations for the diagnosis and management of lupus nephritis in China].
Autorzy :
Zhang H; Department of Rheumatology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Yang NS; Department of Rheumatology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Lu J; Department of Rheumatology, First Affiliated Hospital, China Medical University, Shenyang 110001, China.
Cao H; Department of Rheumatology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Du R; Department of Rheumatology, Union Hospital, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhang W; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
Pokaż więcej
Źródło :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2021 Sep 01; Vol. 60 (9), pp. 784-790.
Typ publikacji :
Journal Article
MeSH Terms :
Lupus Erythematosus, Systemic*
Lupus Nephritis*/diagnosis
Lupus Nephritis*/therapy
China ; Humans ; Kidney ; Remission Induction
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies